128 results
EBM Focus: Boosting Data on Pfizer Vaccine Efficacy
Read about a large, real-time public health study evaluating effectiveness of a third (booster) dose of Pfizer COVID-19 vaccine from the EBM Focus team at DynaMed®.
Five Opportunities to Improve COVID-19 Workflows and Outcomes on the Front Lines
Clinical Decision Support Systems (CDSS) can offer clinicians on the frontlines of the COVID-19 pandemic fast access to evidence-based protocols, but what should be considered when choosing one?
How SARS-CoV-2 Evolution Shapes Public Health: Five Key Turning Points in Mask Recommendations During the COVID-19 Pandemic
Two years into the COVID-19 pandemic, SARS-CoV-2 continues to evolve and public health guidance evolves with it. Here are five key turning points in mask recommendations.
EBM Focus: Doubling Down on Delta with COVID Vaccines — Are They Effective?
In this EBM Focus, DynaMed® editors evaluate a test-negative case-control study evaluating vaccine effectiveness against alpha and delta variants of SARS-COV-2.
EBM Focus: It’s Not the ACE Inhibitors that are killing people with COVID-19
In this EBM Focus article, we delve into the hypothesis that ACE inhibitors could be associated with severe COVID-19, and a study that lets ACE inhibitors off the hook.
By Any Other Name – COVID-19
Do you know which disease name reflects an evil influence from the sky? Dr. Steve Berger from GIDEON (Global Infectious Diseases and Epidemiology Online Network) delves into the history of disease nomenclature, including the most recent — COVID-19
Creation of a COVID-19 Vaccine Decision Aid
Help your patients make an informed choice about the COVID-19 vaccine with a decision aid created by EBSCO Clinical Decisions.
Adenovirus-vectored Vaccines for COVID-19 – How Do They Work?
With millions of people around the world vaccinated with an adenovirus-vectored vaccine for COVID-19, here’s a sneak peek into the body to see how they work.
Viral Rebound After Paxlovid Therapy — What Do We Know?
Cases of viral rebound or COVID rebound are being reported after Paxlovid therapy. Here’s what healthcare practitioners should know about Paxlovid efficacy and rebound.
Tuberculosis Interrupted: How This Infectious Disease Appeared to Decline During the Pandemic but Reclaimed Its Importance as a Global Health Threat
Like other respiratory infections, tuberculosis (TB) cases plummeted during the COVID-19 pandemic. However, unlike other infections, it is likely that TB incidence actually increased due to pandemic-related disruptions in healthcare.